Stock listing

NGM:DBP.B Double Bond Pharmaceutical International AB Aktie

Follow Double Bond Pharmaceutical International AB into a list and get an email when it puts out news.

Double Bond Pharmaceutical International AB logo
Ticker
NGM:DBP.B
Asset type
Stock
Exchange
NGM
Currency
SEK

What changed lately

Latest news

DBP.B: Q1 2026 delivered narrowed losses and major clinical validation for Temodex

May 22, 2026

DBP.B: Equity restored and net loss reduced as SI-053 development progressed, but funding needs persist

Feb 26, 2026

DBP.B: Improved results and restored equity as S1053 advances toward potential partnerships

Nov 13, 2025

DBP.B: Revenue and net loss improved, with strong project progress and a major rights issue launched

Aug 25, 2025

DBP.B: Revenues rose and losses narrowed as SI053 clinical trial preparations were completed

May 22, 2025

DBP.B: Losses narrowed as SI-053 advanced; funding secured, liquidity sufficient into Q3 2025

Feb 26, 2025

DBP.B: SI-053 clinical trial preparations advanced, with improved results and new financing secured

Nov 14, 2024

DBP.B: SI-053 clinical progress and new partnerships drive Double Bond Pharmaceutical's strategic focus

Aug 26, 2024

All Double Bond Pharmaceutical International AB news

Double Bond Pharmaceutical International AB on 6ix

News releases
3 in the last 12 months · 8 in all · newest May 22, 2026 · oldest 2024

Log in to ask 6ix AI your own questions about Double Bond Pharmaceutical International AB.